For Founding Partners & Investors

The infrastructure play in women's healthspan nobody has built yet.

The MoM Overlap Framework™ is a Clinical Operating System sitting at the intersection of Matrescence and Perimenopause — an underserved, high-income demographic with no dedicated platform. We are seeking founding partners to build it.

Start a Conversation Explore the Opportunity
B2B Ecosystem

A high-conversion referral and data engine

Diagnostics & Specialised Care

Direct API integration with Pathology and Radiology labs ensures seamless data ingestion. The framework drives intent-based traffic to partnered Physiotherapy, Nutrition, and Aesthetic clinics that are "MoM-Certified."

Life Sciences & Pharma

Aggregating anonymised datasets to advance research in perimenopausal maternal health — a high-value frontier for Biotech and Pharma with almost no current data infrastructure serving this cohort.

Corporate Wellness

Executive female talent retention is one of the most pressing workforce challenges. Corporate licensing of the MoM Overlap OS offers measurable healthspan metrics and a premium benefit for the 35–55 demographic.

FemTech Platform Integration

Plug-and-play clinical infrastructure for existing health apps. Transitions your platform from a wellness subscription to a clinically rigorous health companion — anchored in NICE, NAMS, AMS, and EMAS standards globally.

How to engage the framework

From full Clinical OS licensing to a fractional advisory role — structured for platforms, corporates, and investors at every stage.

⚙️
B2B / Platform
Clinical OS Licensing

Full integration of the MoM Overlap Framework™ into your FemTech platform, health app, or corporate wellness programme. Includes the Inside-Out Triage Logic, 6 Pillar architecture, and global compliance anchoring.

Enquire →
🩺
Advisory
Fractional Clinical Advisory

Retained engagement as your embedded clinical voice. Ideal for FemTech startups, digital health platforms, or investor-backed ventures requiring clinical credibility and medical governance without a full-time hire.

Enquire →
📋
Clinical
Clinician Education & Training

CME-aligned training for GPs, gynaecologists, and allied health practitioners. Includes the GP Prescription Guide, Clinical Handover Suite, and Bio-Optimisation Bloodwork Checklist.

Enquire →
🔬
Research & Industry
Research Collaboration

Partnership with Biotech, Pharma, and academic institutions seeking clinical insight into perimenopausal maternal health. Includes anonymised data strategy and white-label clinical content development.

Enquire →
🏢
Corporate
Corporate Workshop

A structured half-day or full-day programme for HR leaders and DEI practitioners. Covers the clinical reality of the MoM Overlap and how it affects workforce performance.

Enquire →
🎙️
Speaking
Keynote & Speaking

Evidence-based address on the MoM Overlap, the future of FemTech, or medical gaslighting in the clinic. Available for conferences, summits, and investor forums.

Enquire →
🎧
Media
Podcast Appearance

Dr. Kambarami brings clinical rigour and lived experience to conversations about maternal health, perimenopause, FemTech investment, and the invisible hormonal overlap.

Enquire →
💼
IP
IP Acquisition & Licensing

Full or partial acquisition of the MoM Overlap Framework™ IP suite. Structured LOI available. Retainer advisory roles available post-acquisition.

Enquire →
The Staged Roadmap

From intellectual property to hardware ecosystem

Stage 01 — Now
The Rationale

IP Foundation. Proprietary clinical logic. B2B licensing to Allied Health providers, specialist practitioners, and corporate partners.

Stage 02
The Hub

The MoM Overlap App. Unified Health Dashboard integrating My Health Record, Pathology APIs, and personal self-care in one 360° view.

Stage 03
The Companion

AI Predictive Health Agent. Synthesises biometrics, labs, and recovery data into real-time advice — removing the mental load of health management.

Stage 04
The Sentinel

Proprietary biosensor wearable. High-precision, tuned specifically to the biomarkers of Matrescence and Perimenopause.

Let's build the infrastructure this generation deserves.

We are actively engaging founding partners, clinical collaborators, and strategic investors in the Australian market and beyond.

All enquiries are reviewed personally by Dr. Kambarami. We respond within 48 hours.

What happens next

You'll receive a confirmation within 48 hours
Dr. Kambarami will personally review your enquiry
A discovery call will be scheduled at your convenience
Relevant documentation shared under NDA if appropriate

We respond within 48 hours.

Immediate Next Steps

Three pathways available now.

We are actively engaging founding partners in the AU market. These are the three immediate entry points.

01

Clinical OS White Paper Review

02

Founding Partner Investment Structure (AU Market)

03

Technical Roadmap & MVP Scoping

Get In Touch